Flyrcado flurpiridaz F 18 injection
Flyrcado is a radioactive diagnostic drug indicated for positron emission tomography (PET) myocardial perfusion imaging (MPI) under rest or stress (pharmacologic or exercise) in adult patients with known or suspected coronary artery disease (CAD) to evaluate for myocardial ischemia and infarction.
Now FDA-approved! Available in select markets beginning in early 2025.